EUCTR2007-005911-25-GB进行中（未招募）不适用
A randomised, placebo controlled, double blind study to evaluate the effect of 300mcg testosterone patches in addition to HRT on arterial compliance, insulin resistance and sexual desire. - Testosterone Patch's effect on the Cardiovascular system and libido.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Inclusion Criteria:
- •healthy postmenopausal women
- •45 to 70 years of age
- •on HRT and willing to continue the same HRT regimen for the next 6
- •are in a stable relationship which was started at least 6 months ago
- •continue on any concomitant medications without any change during the
- •give informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Exclusion Criteria:
- •have dyspareunia
- •have received testosterone implants within the last 12 months or other
- •androgen therapy within the last 6 months
- •have received any medications which may interfere with the study (SSRI,
- •anti-androgens, PDE5 inhibitors, DHEA, SERMS)
- •have a significant psychiatric disorder
- •have a history of breast cancer
- •have diabetes, thromboembolic disorders, cardiovascular disease or any
- •condition affecting carbohydrate metabolism, uncontrolled hypertension and uncontrolled hyperlipidaemia
- •are on tibolone (due to its androgenic effect).
研究者
相似试验
已完成
2 期
A placebo controlled multiple dose study of flupirtine in the treatment of painful Human Immunodeficiency Virus (HIV) -associated neuropathy.painful HIV-associated neuropathyInfection - Acquired immune deficiency syndrome (AIDS / HIV)Neurological - Other neurological disordersACTRN12608000315314CNSBio Pty Ltd12
尚未招募
1 期
A study to assess the effectof Withania Somnifera on physical performance, blood parameters of inflammation and muscle status in healthy individuals.CTRI/2019/07/020278I
进行中（未招募）
1 期
A double blind, randomised, placebo-controlled study of the efficacy, safety and tolerability of idebenone in the treatment of patients with Leber's Hereditary Optic Neuropathyeber's Hereditary Optic NeuropathyEUCTR2006-002679-42-GBSanthera Pharmaceuticals (Switzerland) Limited84
进行中（未招募）
不适用
A double blind, randomised, placebo-controlled study to investigate chronic intermittent ''pulse'' therapy of moxifloxacin as a prevention of acute exacerbation in out-patients with chronic bronchitisPrevention of acute exacerbation of chronic bronchitisMedDRA version: NdLevel: PTClassification code 10061735EUCTR2004-000404-40-ITBAYER
进行中（未招募）
不适用
A double blind, randomised, placebo-controlled study of the efficacy, safety and tolerability of idebenone in the treatment of patients with Leber's Hereditary Optic NeuropathyEUCTR2006-002679-42-DESanthera Pharmaceuticals (Switzerland) Limited84